RESILIENCE hjælper dig med at overleve kræft med et stærkt hjerte

Publikationer

Priorities in Cardio-Oncology Basic and Translational Science

GCOS 2023 Symposium Proceedings: JACC: CardioOncology State-of-the-Art Review Despite improvements in cancer survival, cancer therapy–related cardiovascular toxicity has risen to become a prominent clinical challenge. This has led to the growth of the burgeoning field of cardio-oncology, which aims to advance the cardiovascular health of cancer patients and survivors, through

Fortsæt med at læse »

Remote ischaemic conditioning: defining critical criteria for success—report from the 11th Hatter Cardiovascular Workshop

The Hatter Cardiovascular Institute biennial workshop, originally scheduled for April 2020 but postponed for 2 years due to the Covid pandemic, was organised to debate and discuss the future of Remote Ischaemic Conditioning (RIC). This evolved from the large multicentre CONDI-2–ERIC–PPCI outcome study which demonstrated no additional benefit when using

Fortsæt med at læse »

Coronary microcirculation damage in anthracycline cardiotoxicity

By using a highly translatable large-animal model, this work shows that cumulative exposure to anthracycline results in an irreversible damage to the heart microcirculation. The microcirculation injury is observed even before overt left ventricular cardiac systolic dysfunction (surrogate for overt cardiotoxicity) is present. Cardiac microcirculation damage is associated with poor

Fortsæt med at læse »
Logotipo Resilience

Er du en patient, der deltager i RESILIENCE-forsøget? Her finder du nyttige oplysninger om detaljerne i din deltagelse og aktiviteter specielt designet til dig. Du vil også kunne kontakte RESILIENCE-forskerne direkte.

Dine data anvendes til at besvare forespørgsler, sende kommunikation og udføre statistiske analyser. For mere information om behandlingen og dine rettigheder henvises til privatlivspolitikken.